Valeant Pharmaceuticals ups offer for Allergan to $49.5 billion
Wednesday, May 28, 2014 - 09:31
in Mathematics & Economics
Ananth BaligaIRVINE, Calif., May 28 (UPI) -- Valeant Pharmaceuticals is sweetening its deal to take over botox-maker Allergan by increasing the cash component by $10 a share to $58.30.